PAGET'S DISEASE OF THE BONE FOUND INCIDENTALLY ON F-18 FDG PET/CT: CLINICAL SIGNIFICANCE AND DIFFERENTIAL DIAGNOSTIC CRITERIA

Basit Öğe Kaydı
dc.authoridCelik, Mehmet/0000-0001-7364-370X
dc.contributor.authorUestuen, F.
dc.contributor.authorUstabasioglu, F. E.
dc.contributor.authorTokuc, B.
dc.contributor.authorBuelbuel, B. Yimaz
dc.contributor.authorCelik, M.
dc.contributor.authorAytuerk, S.
dc.date.accessioned2024-10-29T17:59:32Z
dc.date.available2024-10-29T17:59:32Z
dc.date.issued2023
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstractBackground. Paget Disease (PD) is usually asymptomatic and discovered incidentally, it is known that it is exhibited low to high grade increased F-18 FDG uptake. Aim. In this study, we investigated the distinguishability of FDG PET/CT in incidental PD cases from other bone diseases and at different stages of the disease. Patients and Methods. In this cross-sectional, descriptive study, Paget identification associated with PET/CT reports was found in 69 of 18,119 studies (similar to 3.8%). Of the 45 patients (33 males and 12 females) eligible for inclusion in the study, 35.6% had monostotic and 64.4% had polyostotic disease (p>0.5). There was no statistically significant difference in biochemical parameters between groups. Results. According to the radiological appearance of the patients, 36 were in the mixed stage and 9 were in the blastic stage. Only the difference in ALP and creatinine values between the groups was statistically significant. SUVmax, SUVmean and HU values were found to be statistically significantly higher in pagetoid bones compared to control bone lesions. For SUVmax for PD bone lesion we found the 2.55 cutoff point with a sensitivity of 91% and a specificity of 84%. Conclusion. The specific radiological appearance of bone lesions and the evaluation of metabolic activity compared to normal bone seem to help differentiate PD from other lesions. Prospective studies are needed in the differentiation of FDG's disease stage and treatment response evaluation. The ability to differentiate between benign and malignant FDG avid bone lesions in oncological patients' enables appropriate patient management, including avoiding unnecessary additional invasive procedures such as bone biopsy.
dc.identifier.doi10.4183/aeb.2023.292
dc.identifier.endpage300
dc.identifier.issn1841-0987
dc.identifier.issn1843-066X
dc.identifier.issue3en_US
dc.identifier.pmid38356987
dc.identifier.scopus2-s2.0-85184442364
dc.identifier.scopusqualityQ4
dc.identifier.startpage292
dc.identifier.urihttps://doi.org/10.4183/aeb.2023.292
dc.identifier.urihttps://hdl.handle.net/20.500.11776/14764
dc.identifier.volume19
dc.identifier.wosWOS:001203269900011
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherEditura Acad Romane
dc.relation.ispartofActa Endocrinologica-Bucharest
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectPaget disease
dc.subjectF-18 FDG PET/CT
dc.subjectincidental bone lesion
dc.titlePAGET'S DISEASE OF THE BONE FOUND INCIDENTALLY ON F-18 FDG PET/CT: CLINICAL SIGNIFICANCE AND DIFFERENTIAL DIAGNOSTIC CRITERIA
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu